Form 8-K - Current report:
SEC Accession No. 0001193125-22-005070
Filing Date
2022-01-10
Accepted
2022-01-10 07:31:46
Documents
54
Period of Report
2022-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d143088d8k.htm   iXBRL 8-K 24500
2 EX-99.1 d143088dex991.htm EX-99.1 38013
6 GRAPHIC g143088ex99_1s10g1.jpg GRAPHIC 316797
7 GRAPHIC g143088ex99_1s11g1.jpg GRAPHIC 298161
8 GRAPHIC g143088ex99_1s12g1.jpg GRAPHIC 285972
9 GRAPHIC g143088ex99_1s13g1.jpg GRAPHIC 364630
10 GRAPHIC g143088ex99_1s14g1.jpg GRAPHIC 268943
11 GRAPHIC g143088ex99_1s15g1.jpg GRAPHIC 368352
12 GRAPHIC g143088ex99_1s16g1.jpg GRAPHIC 287714
13 GRAPHIC g143088ex99_1s17g1.jpg GRAPHIC 223397
14 GRAPHIC g143088ex99_1s18g1.jpg GRAPHIC 231823
15 GRAPHIC g143088ex99_1s19g1.jpg GRAPHIC 366707
16 GRAPHIC g143088ex99_1s1g1.jpg GRAPHIC 444108
17 GRAPHIC g143088ex99_1s20g1.jpg GRAPHIC 310403
18 GRAPHIC g143088ex99_1s21g1.jpg GRAPHIC 281118
19 GRAPHIC g143088ex99_1s22g1.jpg GRAPHIC 259178
20 GRAPHIC g143088ex99_1s23g1.jpg GRAPHIC 272536
21 GRAPHIC g143088ex99_1s24g1.jpg GRAPHIC 164586
22 GRAPHIC g143088ex99_1s25g1.jpg GRAPHIC 301412
23 GRAPHIC g143088ex99_1s26g1.jpg GRAPHIC 161779
24 GRAPHIC g143088ex99_1s27g1.jpg GRAPHIC 236604
25 GRAPHIC g143088ex99_1s28g1.jpg GRAPHIC 230497
26 GRAPHIC g143088ex99_1s29g1.jpg GRAPHIC 335762
27 GRAPHIC g143088ex99_1s2g1.jpg GRAPHIC 883582
28 GRAPHIC g143088ex99_1s30g1.jpg GRAPHIC 294843
29 GRAPHIC g143088ex99_1s31g1.jpg GRAPHIC 250629
30 GRAPHIC g143088ex99_1s32g1.jpg GRAPHIC 349001
31 GRAPHIC g143088ex99_1s33g1.jpg GRAPHIC 231640
32 GRAPHIC g143088ex99_1s34g1.jpg GRAPHIC 275169
33 GRAPHIC g143088ex99_1s35g1.jpg GRAPHIC 317020
34 GRAPHIC g143088ex99_1s36g1.jpg GRAPHIC 243571
35 GRAPHIC g143088ex99_1s37g1.jpg GRAPHIC 325738
36 GRAPHIC g143088ex99_1s38g1.jpg GRAPHIC 288670
37 GRAPHIC g143088ex99_1s39g1.jpg GRAPHIC 226412
38 GRAPHIC g143088ex99_1s3g1.jpg GRAPHIC 285971
39 GRAPHIC g143088ex99_1s40g1.jpg GRAPHIC 389580
40 GRAPHIC g143088ex99_1s41g1.jpg GRAPHIC 414919
41 GRAPHIC g143088ex99_1s4g1.jpg GRAPHIC 294531
42 GRAPHIC g143088ex99_1s5g1.jpg GRAPHIC 270978
43 GRAPHIC g143088ex99_1s6g1.jpg GRAPHIC 202466
44 GRAPHIC g143088ex99_1s7g1.jpg GRAPHIC 230864
45 GRAPHIC g143088ex99_1s8g1.jpg GRAPHIC 286741
46 GRAPHIC g143088ex99_1s9g1.jpg GRAPHIC 267537
  Complete submission text file 0001193125-22-005070.txt   17202963

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA glue-20220110.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE glue-20220110_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glue-20220110_pre.xml EX-101.PRE 11857
48 EXTRACTED XBRL INSTANCE DOCUMENT d143088d8k_htm.xml XML 3478
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40522 | Film No.: 22519699
SIC: 2836 Biological Products, (No Diagnostic Substances)